Into the Eye of the Cytokine Storm
暂无分享,去创建一个
Michael G. Katze | Cameron P. Simmons | Thomas R. Martin | M. Katze | J. Farrar | M. J. Korth | J. Tisoncik | C. Simmons | T. Martin | Marcus J. Korth | Jeremy Farrar | Jennifer R. Tisoncik
[1] J. Farrar,et al. Insights into inflammation and influenza. , 2008, The New England journal of medicine.
[2] D. Zeldin,et al. Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice , 2010, PloS one.
[3] A. Attaran,et al. Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study , 2008, PloS one.
[4] P. Holt,et al. Regulation of immunological homeostasis in the respiratory tract , 2008, Nature Reviews Immunology.
[5] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[6] N. Voirin,et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock , 2006, Intensive Care Medicine.
[7] P. Österlund,et al. Pandemic H1N1 2009 Influenza A Virus Induces Weak Cytokine Responses in Human Macrophages and Dendritic Cells and Is Highly Sensitive to the Antiviral Actions of Interferons , 2009, Journal of Virology.
[8] J. Ferrara,et al. Cytokine dysregulation as a mechanism of graft versus host disease. , 1993, Current opinion in immunology.
[9] I. Clark. How TNF was recognized as a key mechanism of disease. , 2007, Cytokine & growth factor reviews.
[10] R. Friedman. Clinical uses of interferons. , 2008, British journal of clinical pharmacology.
[11] Arthur S Slutsky,et al. Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury , 2008, Cell.
[12] G. Janossy,et al. Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited , 2000, Bone Marrow Transplantation.
[13] Lei Sun,et al. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[14] R. Danner,et al. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. , 1993, The New England journal of medicine.
[15] E. Ramsburg,et al. CCR2-Antagonist Prophylaxis Reduces Pulmonary Immune Pathology and Markedly Improves Survival during Influenza Infection , 2011, The Journal of Immunology.
[16] P. Suter,et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. , 1996, American journal of respiratory and critical care medicine.
[17] Osamu Takeuchi,et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.
[18] B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.
[19] I. Clark,et al. Increased Survival after Gemfibrozil Treatment of Severe Mouse Influenza , 2007, Antimicrobial Agents and Chemotherapy.
[20] S. Imashuku. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. , 2002, Critical reviews in oncology/hematology.
[21] A. Kingsnorth,et al. Cytokine storm in acute pancreatitis. , 2002, Journal of hepato-biliary-pancreatic surgery.
[22] Houli Wang,et al. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. , 2008, The American journal of emergency medicine.
[23] J. Farrar,et al. Pretreatment Intracerebral and Peripheral Blood Immune Responses in Vietnamese Adults with Tuberculous Meningitis: Diagnostic Value and Relationship to Disease Severity and Outcome , 2006, The Journal of Immunology.
[24] S. Akira,et al. Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.
[25] E. Cordero,et al. Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. , 2011, The Journal of infection.
[26] Hung-Yi Wu,et al. Upregulation of the Chemokine (C-C Motif) Ligand 2 via a Severe Acute Respiratory Syndrome Coronavirus Spike-ACE2 Signaling Pathway , 2010, Journal of Virology.
[27] R. Centor,et al. Development of the adult respiratory distress syndrome: progressive alteration of neutrophil chemotactic and secretory processes. , 1984, The American journal of pathology.
[28] S. McColl,et al. Mini‐review series: focus on chemokines , 2011, Immunology and cell biology.
[29] A. Luster,et al. CXCR3 ligands: redundant, collaborative and antagonistic functions , 2011, Immunology and cell biology.
[30] B. Beutler,et al. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.
[31] Osamu Takeuchi,et al. Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.
[32] R. Webster,et al. H5N1 Influenza Virus Pathogenesis in Genetically Diverse Mice Is Mediated at the Level of Viral Load , 2011, mBio.
[33] Kaoru Tominaga,et al. Activation of innate immune antiviral response by NOD2 , 2009, Nature Immunology.
[34] M. Wurfel. Genetic insights into sepsis: what have we learned and how will it help? , 2008, Current pharmaceutical design.
[35] J. Farrar,et al. Timing of CD8+ T Cell Responses in Relation to Commencement of Capillary Leakage in Children with Dengue , 2010, The Journal of Immunology.
[36] T. Tumpey,et al. Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice , 2006, Journal of Virology.
[37] C. Brocker,et al. Evolutionary divergence and functions of the human interleukin (IL) gene family , 2010, Human Genomics.
[38] I. Humphreys,et al. TGF-beta prevents eosinophilic lung disease but impairs pathogen clearance. , 2005, Microbes and infection.
[39] R. Proia,et al. The alliance of sphingosine-1-phosphate and its receptors in immunity , 2008, Nature Reviews Immunology.
[40] Ann Richmond,et al. Chemokines in health and disease. , 2011, Experimental cell research.
[41] David E. Swayne,et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus , 2006, Nature.
[42] S. Kalayanarooj,et al. Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever , 2006, Journal of Virology.
[43] Carole R. Baskin,et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus , 2009, Proceedings of the National Academy of Sciences.
[44] K. Asadullah,et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.
[45] R. Albrecht,et al. Experimental Infection of Pigs with the Human 1918 Pandemic Influenza Virus , 2009, Journal of Virology.
[46] S. Yokota. [Influenza-associated encephalopathy--pathophysiology and disease mechanisms]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.
[47] D. Golenbock,et al. Malaria primes the innate immune response due to interferon-γ induced enhancement of toll-like receptor expression and function , 2009, Proceedings of the National Academy of Sciences.
[48] Clark,et al. Possible importance of macrophage-derived mediators in acute malaria , 1981, Infection and immunity.
[49] H. Bruining,et al. p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock: A Randomized Controlled Multicenter Trial , 1997 .
[50] Chengjun Li,et al. Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems , 2011, BMC Systems Biology.
[51] Lucy A. Perrone,et al. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. , 2010, The Journal of infectious diseases.
[52] J. Peiris,et al. Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.
[53] J. Pugin,et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.
[54] K. Silamut,et al. Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.
[55] R. Schumann,et al. Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. , 2006, The Journal of infectious diseases.
[56] Yi Guan,et al. Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro , 2010, Respiratory research.
[57] C. Dinarello,et al. Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.
[58] J. Alcorn,et al. Critical Role of IL-17RA in Immunopathology of Influenza Infection , 2009, The Journal of Immunology.
[59] A. Garin,et al. Chemokines as targets for therapy. , 2011, Experimental cell research.
[60] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[61] J. Renauld,et al. Interferon-λ Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses , 2008, PLoS pathogens.
[62] T. Hussell,et al. Structured regulation of inflammation during respiratory viral infection. , 2010, The Lancet. Infectious diseases.
[63] L. Hung,et al. Antiarrhythmic Effect of Magnolol and Honokiol during Acute Phase of Coronary Occlusion in Anesthetized Rats: Influence of L-NAME and Aspirin , 1999, Pharmacology.
[64] Michael G. Katze,et al. Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity , 2007, Journal of Virology.
[65] A. Bisno,et al. Molecular basis of group A streptococcal virulence. , 2003, The Lancet. Infectious diseases.
[66] Yi Guan,et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.
[67] I. Humphreys,et al. A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection , 2003, The Journal of experimental medicine.
[68] Jean H. Chang,et al. Host Regulatory Network Response to Infection with Highly Pathogenic H5N1 Avian Influenza Virus , 2011, Journal of Virology.
[69] T. Martin,et al. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. , 1999, The Journal of clinical investigation.
[70] M. Bachmann,et al. Averting inflammation by targeting the cytokine environment , 2010, Nature Reviews Drug Discovery.
[71] Nicki Panoskaltsis,et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. , 2006, The New England journal of medicine.
[72] T. Sawa,et al. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU* , 2004, Critical care medicine.
[73] Yoshihiro Kawaoka,et al. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection , 2009, Proceedings of the National Academy of Sciences.
[74] Michael G. Katze,et al. Innate immune modulation by RNA viruses: emerging insights from functional genomics , 2008, Nature Reviews Immunology.
[75] W. Junger,et al. Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.
[76] R. Beyaert,et al. A20: Central Gatekeeper in Inflammation and Immunity* , 2009, Journal of Biological Chemistry.
[77] Jonathan Cohen. The immunopathogenesis of sepsis , 2002, Nature.
[78] D. J. Arora,et al. Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase. , 1990, Cellular immunology.
[79] E. Ramsburg,et al. CCR2+ Monocyte-Derived Dendritic Cells and Exudate Macrophages Produce Influenza-Induced Pulmonary Immune Pathology and Mortality1 , 2008, The Journal of Immunology.
[80] Lei Zhu,et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury , 1997, Molecular microbiology.
[81] T. Akazawa,et al. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction , 2003, Nature Immunology.
[82] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[83] R. Schumann,et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. , 2006, The Journal of communicable diseases.
[84] M. Neumann,et al. Peroxisome proliferator‐activated receptor‐γ agonists inhibit respiratory syncytial virus‐induced expression of intercellular adhesion molecule‐1 in human lung epithelial cells , 2007 .
[85] H. Yen,et al. Host response to influenza virus: protection versus immunopathology. , 2010, Current opinion in immunology.
[86] M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.
[87] Ralph S. Baric,et al. SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism , 2010, PLoS pathogens.
[88] G. Dougan,et al. OX40 Ligation on Activated T Cells Enhances the Control of Cryptococcus neoformans and Reduces Pulmonary Eosinophilia , 2003, The Journal of Immunology.
[89] H. Link. The cytokine storm in multiple sclerosis , 1998, Multiple sclerosis.
[90] P. Doherty,et al. A question of self‐preservation: immunopathology in influenza virus infection , 2007, Immunology and cell biology.
[91] A. Rothman,et al. Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo , 2009, Journal of medical virology.
[92] Samson S. Y. Wong,et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus , 2008, Proceedings of the National Academy of Sciences.
[93] A. Nisalak,et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.
[94] Ali Danesh,et al. Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome , 2007, Journal of Virology.
[95] Yan Li,et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus , 2007, Nature.
[96] R. Webster,et al. Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial Cells , 2002, Journal of Virology.
[97] M. Katze,et al. Pandemic Swine-Origin H1N1 Influenza A Virus Isolates Show Heterogeneous Virulence in Macaques , 2010, Journal of Virology.
[98] Scott R. Presnell,et al. IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.
[99] D. Gemsa,et al. Influenza A virus infects macrophages and stimulates release of tumor necrosis factor-alpha. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.
[100] A. Barclay,et al. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection , 2008, Nature Immunology.
[101] Graham R. Foster,et al. Interferons at age 50: past, current and future impact on biomedicine , 2007, Nature Reviews Drug Discovery.
[102] David B. Goldstein,et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.
[103] P. Openshaw,et al. Inhibition of tumor necrosis factor reduces the severity of virus‐specific lung immunopathology , 2001, European journal of immunology.
[104] I. Humphreys,et al. TGF-β prevents eosinophilic lung disease but impairs pathogen clearance , 2005 .
[105] T. Martin,et al. Animal models of acute lung injury , 2008, American journal of physiology. Lung cellular and molecular physiology.
[106] Peter Tontonoz,et al. Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.
[107] Diane P. Martin,et al. Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.
[108] Xinxia Peng,et al. Lethal Influenza Virus Infection in Macaques Is Associated with Early Dysregulation of Inflammatory Related Genes , 2009, PLoS pathogens.
[109] A. Murphy,et al. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung , 2011, Proceedings of the National Academy of Sciences.
[110] L. Chess,et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.
[111] T. van der Poll,et al. Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia. , 2007, Clinical immunology.
[112] P. Sly,et al. TLR4 Polymorphisms Mediate Impaired Responses to Respiratory Syncytial Virus and Lipopolysaccharide1 , 2007, The Journal of Immunology.
[113] L. Joosten,et al. IL-1 family nomenclature , 2010, Nature Immunology.
[114] J. Farrar,et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. , 2007, The Journal of infectious diseases.
[115] M. Rieder,et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. , 2008, American journal of respiratory and critical care medicine.
[116] Jacques Fellay,et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.
[117] Yoshihiro Kawaoka,et al. Avian flu: Influenza virus receptors in the human airway , 2006, Nature.
[118] Y. Guan,et al. Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation , 2010, Virology.
[119] J. Pugin,et al. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. , 2001, American journal of respiratory and critical care medicine.
[120] W. Bos,et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial , 2011, The Lancet.
[121] H. Bruining,et al. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. , 1997, JAMA.
[122] I. Clark,et al. The advent of the cytokine storm , 2007, Immunology and cell biology.
[123] G. Sen,et al. Interferons and viral infections , 2009, BioFactors.
[124] Robert Peach,et al. Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection , 2011, Cell.
[125] Tao Dong,et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever , 2003, Nature Medicine.
[126] N. M. Dung,et al. Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection. , 2009, The Journal of infectious diseases.
[127] G. Gudmundsson,et al. Respiratory Syncytial Virus Up-regulates TLR4 and Sensitizes Airway Epithelial Cells to Endotoxin* , 2003, Journal of Biological Chemistry.
[128] J. Tregoning,et al. Role of CCL5 (RANTES) in Viral Lung Disease , 2006, Journal of Virology.
[129] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[130] Y. Guan,et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.
[131] J. Bassaganya-Riera,et al. PPAR-gamma activation as an anti-inflammatory therapy for respiratory virus infections. , 2010, Viral immunology.
[132] Chris T. A. Evelo,et al. Presenting and exploring biological pathways with PathVisio , 2008, BMC Bioinformatics.
[133] J. Ferrara,et al. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. , 1993, Transplantation proceedings.
[134] David E. Swayne,et al. Genomic Profiling of Tumor Necrosis Factor Alpha (TNF-α) Receptor and Interleukin-1 Receptor Knockout Mice Reveals a Link between TNF-α Signaling and Increased Severity of 1918 Pandemic Influenza Virus Infection , 2010, Journal of Virology.
[135] M. Katze,et al. 2009 Pandemic H1N1 Influenza Virus Causes Disease and Upregulation of Genes Related to Inflammatory and Immune Responses, Cell Death, and Lipid Metabolism in Pigs , 2011, Journal of Virology.
[136] Pedro Romero,et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. , 2011, Immunity.
[137] Xinxia Peng,et al. Lethal Dissemination of H5N1 Influenza Virus Is Associated with Dysregulation of Inflammation and Lipoxin Signaling in a Mouse Model of Infection , 2010, Journal of Virology.
[138] Martin F. Bachmann,et al. Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection , 2005, Journal of Virology.
[139] D. Relman,et al. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[140] Dirk E. Smith,et al. The IL-1 family: regulators of immunity , 2010, Nature Reviews Immunology.
[141] J. Hamilton. Colony-stimulating factors in inflammation and autoimmunity , 2008, Nature Reviews Immunology.
[142] K. Yuen,et al. Human infection by avian influenza A H5N1. , 2005, Hong Kong medical journal = Xianggang yi xue za zhi.
[143] Niall J. Lennon,et al. The Early Whole-Blood Transcriptional Signature of Dengue Virus and Features Associated with Progression to Dengue Shock Syndrome in Vietnamese Children and Young Adults , 2010, Journal of Virology.
[144] R. Rylander,et al. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. , 2003, The Journal of allergy and clinical immunology.
[145] Y. Guan,et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. , 2008, The Journal of infectious diseases.
[146] Y. Guan,et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells , 2005, Respiratory research.
[147] G. Prestwich,et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.
[148] Arthur S Slutsky,et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. , 2003, JAMA.
[149] L. Brochard,et al. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. , 2011, American journal of respiratory and critical care medicine.
[150] B. Aggarwal,et al. Targeting TNF for Treatment of Cancer and Autoimmunity. , 2009, Advances in experimental medicine and biology.
[151] Ivana V. Yang,et al. Genetic analysis of complex traits in the emerging Collaborative Cross. , 2011, Genome research.
[152] David M. Tobin,et al. The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans , 2010, Cell.
[153] M. Katze,et al. Transcriptomic Analysis Reveals a Mechanism for a Prefibrotic Phenotype in STAT1 Knockout Mice during Severe Acute Respiratory Syndrome Coronavirus Infection , 2010, Journal of Virology.
[154] S. Akira,et al. Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.
[155] D. Kwiatkowski,et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. , 1998, The Journal of infectious diseases.
[156] M. Gale,et al. Immune signaling by RIG-I-like receptors. , 2011, Immunity.
[157] J. Peiris,et al. Innate immune responses to influenza A H5N1: friend or foe? , 2009, Trends in immunology.
[158] Roger E Bumgarner,et al. Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity , 2006, The Journal of Immunology.
[159] S. Kaveri,et al. CISH and susceptibility to infectious diseases. , 2010, The New England journal of medicine.
[160] Kim L Kusser,et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity , 2004, Nature Medicine.
[161] Natalia Novoselova,et al. Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection. , 2010, Microbes and infection.